EN DE
STOCK COMPARISON

Hansoh Pharmaceutical Group Co vs Jiangsu Hengrui Medicine Co: Fair Value & Quality

Both stocks run through our valuation models. Here is how Hansoh Pharmaceutical Group Co (3692) and Jiangsu Hengrui Medicine Co (600276) compare, as of Aug 8, 2026.

As of Aug 8, 2026, Fair Value Calculator sees Hansoh Pharmaceutical Group Co as the less overvalued of the two: Hansoh Pharmaceutical Group Co trades at HK$31.68 versus a fair value of HK$18.00 (-43%), while Jiangsu Hengrui Medicine Co trades at ¥52.11 versus ¥25.94 (-50%).
Hansoh Pharmaceutical Group Co
3692.HK · HKD · Health Care
-43%
upside to fair value
overvalued
PriceHK$31.68
Fair ValueHK$18.00
Quality64/100
Jiangsu Hengrui Medicine Co
600276.SHG · CNY · Health Care
-50%
upside to fair value
overvalued
Price¥52.11
Fair Value¥25.94
Quality59/100

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

Hansoh Pharmaceutical Group CoJiangsu Hengrui Medicine Co
Valuation
30.7×P/E (TTM)43.6×
13.25×P/S (TTM)10.84×
5.63×P/B5.76×
34.0×EV/EBITDA33.0×
—PEG0.93×
1.2%Dividend yield0.4%
HK$0.39Dividend per share¥0.20
Profitability
37%Net margin25%
30%Operating margin32%
17%Return on equity15%
9%Return on assets9%
Growth
32%Revenue growth (YoY)13%
17.0%Avg. growth/yr (3Y)13.9%
11.6%Avg. growth/yr (5Y)2.5%
Balance & size
$25BMarket cap$52B
healthyGrowth qualityhealthy

Hansoh Pharmaceutical Group Co leads: 9 to 3 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

Hansoh Pharmaceutical Group Coof which business quality 74 · market factors 39 Jiangsu Hengrui Medicine Coof which business quality 68 · market factors 42
ProfitabilityMargins and returns on capital today
65
63
Quality GrowthAre margins and returns improving?
62
41
CashflowEarnings quality: real cash, not paper profit
86
82
Fin. StrengthBalance sheet, leverage, solvency risk
86
100
InvestmentDisciplined investing over empire-building
54
27
Low VolatilityCalm price path (market factor)
71
78
MomentumPrice trend over the last 3–12 months (market factor)
26
30
52W MomentumDistance to the 52-week high (market factor)
25
23
Net IssuanceBuybacks instead of dilution
78
64

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

Hansoh Pharmaceutical Group Co

DCF ModelsHK$20.98
Earnings-BasedHK$11.93
Dividend DiscountHK$5.84
MultiplesHK$14.30
Asset-BasedHK$3.91
Growth DCFHK$18.38
Economic ProfitHK$9.59
Growth EarningsHK$17.83

26 of 26 models see the stock below the current price.

Jiangsu Hengrui Medicine Co

DCF Models¥37.11
Earnings-Based¥21.29
Dividend Discount¥3.82
Multiples¥22.37
Asset-Based¥6.44
Growth DCF¥38.47
Economic Profit¥18.21
Growth Earnings¥29.68

26 of 26 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

Hansoh Pharmaceutical Group Co
Bear HK$13.50Fair Value HK$18.00Bull HK$28.17
HK$31.68 = current price (white tick)
Jiangsu Hengrui Medicine Co
Bear ¥19.95Fair Value ¥25.94Bull ¥40.28
¥52.11 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

Hansoh Pharmaceutical Group Co · Health Care

Quality score64 · Top 25%
Fair value upside-43% · below median

Jiangsu Hengrui Medicine Co · Health Care

Quality score59 · Top 25%
Fair value upside-50% · below median

Bottom line

As of Aug 8, 2026, Fair Value Calculator sees Hansoh Pharmaceutical Group Co as the less overvalued of the two: Hansoh Pharmaceutical Group Co trades at HK$31.68 versus a fair value of HK$18.00 (-43%), while Jiangsu Hengrui Medicine Co trades at ¥52.11 versus ¥25.94 (-50%).

Hansoh Pharmaceutical Group Co has the higher quality score (64/100).

See the full analysis →
Hansoh Pharmaceutical Group Co · Jiangsu Hengrui Medicine Co

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Related to Hansoh Pharmaceutical Group Co

Eli Lilly and vs UnitedHealth GroupJohnson & Johnson vs UnitedHealth GroupAbbVie vs UnitedHealth GroupUnitedHealth Group vs Merck & Company

Related to Jiangsu Hengrui Medicine Co

UnitedHealth Group vs AstraZenecaUnitedHealth Group vs Thermo Fisher ScientificUnitedHealth Group vs AmgenUnitedHealth Group vs Abbott Laboratories
Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.